UMC119-06-05

N/A

Report date: 2023/01/12 15:46:49

Base Information

Drug NameUMC119-06-05
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsFrailtyOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeridigen Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeridigen Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsFrailtyOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A